Our studies on fibroblasts derived from SoS patients and healthy controls demonstrated that NSD1 mutations result in changes in the expression of long noncoding RNAs and genes associated with neoplastic differentiation, particularly those that regulate the G2/M checkpoint [18]. Here, NSD1 is linked to spondylo-ocular syndrome.